Video

Q&A With Paul Hudson of AstraZeneca US: 'Excitement' in Diabetes Treatment Progress

Author(s):

With so many people affected by diabetes finding the right treatment for the individual patients is becoming a key factor in care.

With so many people affected by diabetes finding the right treatment for the individual patients is becoming a key factor in care.

Paul Hudson, President of AstraZeneca US discussed some of the work the company is doing during the American Diabetes Association's 75th Annual Scientific Sessions in Boston. Hudson said much of the excitement centers around Forxiga which can be used in combination therapy.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.